Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.replimune.com
Replimune News Releases
Get the latest updates from Replimune News Releases directly as they happen.
Follow now 39 followers
Latest posts
Last updated 5 days ago
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 days ago
WOBURN, Mass. , May 09, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
about 1 month ago
WOBURN, Mass. , April 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago
WOBURN, Mass. , March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
3 months ago
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application...
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago
WOBURN, Mass. , Feb. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma
4 months ago
PDUFA action date of July 22, 2025, with priority review WOBURN, Mass...
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago
WOBURN, Mass. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
4 months ago
WOBURN, Mass. , Jan. 08, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference
5 months ago
WOBURN, Mass. , Dec. 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc...
Replimune Announces Pricing of Upsized Public Offering
6 months ago
BOSTON , Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group , Inc...
Replimune Announces Proposed Public Offering
6 months ago
WOBURN, Mass. , Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group...
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
6 months ago
WOBURN, Mass. , Nov. 21, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc...